Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

The effect of laparoscopic guidance on gynecologic interstitial brachytherapy.

Engle DB, Bradley KA, Chappell RJ, Conner JP, Hartenbach EM, Kushner DM.

J Minim Invasive Gynecol. 2008 Sep-Oct;15(5):541-6. doi: 10.1016/j.jmig.2008.06.001. Epub 2008 Jul 26.

PMID:
18657479
2.

Potential decreased morbidity of interstitial brachytherapy for gynecologic malignancies using laparoscopy: A pilot study.

Choi JC, Ingenito AC, Nanda RK, Smith DH, Wuu CS, Chin LJ, Schiff PB.

Gynecol Oncol. 1999 May;73(2):210-5. Review.

PMID:
10329036
3.

Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies.

Kasibhatla M, Clough RW, Montana GS, Oleson JR, Light K, Steffey BA, Jones EL.

Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):398-403. Epub 2006 Mar 20.

PMID:
16542793
4.

Laparoscopic-assisted application of interstitial brachytherapy for locally advanced cervical carcinoma: results of a pilot study.

Recio FO, Piver MS, Hempling RE, Eltabbakh GH, Hahn S.

Int J Radiat Oncol Biol Phys. 1998 Jan 15;40(2):411-4.

PMID:
9457829
5.

Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.

Yaparpalvi R, Mutyala S, Gorla GR, Butler J, Mah D, Garg MK, Kalnicki S.

Brachytherapy. 2008 Oct-Dec;7(4):336-42. doi: 10.1016/j.brachy.2008.05.005. Epub 2008 Sep 7.

PMID:
18782683
6.

Laparoscopy-assisted intracavitary radiotherapy tandem placement for patients with cervical cancer.

Lim MC, Jung DC, Kim JY, Park SY.

Int J Gynecol Cancer. 2009 Aug;19(6):1125-30. doi: 10.1111/IGC.0b013e3181ab5965.

PMID:
19820380
7.

High-dose-rate interstitial brachytherapy in the management of carcinoma of the uterine cervix and other gynecologic malignancies.

Sitathanee C, Pairatchvet V, Narkwong L, Puataweepong P.

J Med Assoc Thai. 2005 Aug;88(8):1045-50.

PMID:
16404830
8.

Permanent interstitial reirradiation with 198Au as salvage therapy for low volume recurrent gynecologic malignancies: a single institution experience.

Brabham JG, Cardenes HR.

Am J Clin Oncol. 2009 Aug;32(4):417-22. doi: 10.1097/COC.0b013e318191bfc7.

PMID:
19451799
9.

Sentinel lymph node identification and radical hysterectomy with lymphadenectomy in early stage cervical cancer: laparoscopy versus laparotomy.

Díaz-Feijoo B, Gil-Moreno A, Pérez-Benavente MA, Morchón S, Martínez-Palones JM, Xercavins J.

J Minim Invasive Gynecol. 2008 Sep-Oct;15(5):531-7. doi: 10.1016/j.jmig.2008.04.015. Epub 2008 Jul 26.

PMID:
18657483
10.

Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.

Huguet F, Cojocariu OM, Levy P, Lefranc JP, Darai E, Jannet D, Ansquer Y, Lhuillier PE, Benifla JL, Seince N, Touboul E.

Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1508-15. doi: 10.1016/j.ijrobp.2008.03.054.

PMID:
18676093
12.

Clinical application and midterm results of laparoscopic partial resection of symptomatic adenomyosis combined with uterine artery occlusion.

Kang L, Gong J, Cheng Z, Dai H, Liping H.

J Minim Invasive Gynecol. 2009 Mar-Apr;16(2):169-73. doi: 10.1016/j.jmig.2008.12.003.

PMID:
19249704
13.

Total laparoscopic hysterectomy versus laparoscopic-assisted vaginal hysterectomy in endometrial cancer: surgical and survival outcomes.

Fader AN, Michener CM, Frasure HE, Giannios N, Belinson JL, Zanotti KM.

J Minim Invasive Gynecol. 2009 May-Jun;16(3):333-9. doi: 10.1016/j.jmig.2009.02.010.

PMID:
19423064
14.

Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients.

Chargari C, Magné N, Dumas I, Messai T, Vicenzi L, Gillion N, Morice P, Haie-Meder C.

Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):133-9. doi: 10.1016/j.ijrobp.2008.06.1912. Epub 2008 Sep 5.

PMID:
18774656
16.

Outcomes of high dose rate interstitial boost brachytherapy after external beam radiation therapy in head and neck cancer--an Indian (single institutional) learning experience.

Patra NB, Goswami J, Basu S, Chatterjee K, Sarkar SK.

Brachytherapy. 2009 Apr-Jun;8(2):248-54. doi: 10.1016/j.brachy.2008.12.006. Epub 2009 Feb 20.

PMID:
19230791
17.

Critical organ preservation in reirradiation brachytherapy by injectable spacer.

Kishi K, Sonomura T, Shirai S, Sato M, Tanaka K.

Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):587-94. doi: 10.1016/j.ijrobp.2009.03.072.

PMID:
19735885
18.

Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.

Parker K, Gallop-Evans E, Hanna L, Adams M.

Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):140-6. doi: 10.1016/j.ijrobp.2008.06.1920. Epub 2008 Oct 14.

PMID:
18922646
19.

Geometrical sparing factors for the rectum and bladder in the prediction of grade 2 and higher complications after high-dose-rate brachytherapy for cervical cancer.

Chen SW, Liang JA, Hung YC, Yeh LS, Chang WC, Yang SN, Lin FJ.

Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1335-43. doi: 10.1016/j.ijrobp.2008.12.018. Epub 2009 Apr 20.

PMID:
19386443
20.

Extended-field radiation therapy with whole pelvis radiotherapy and cisplatin chemosensitization in the treatment of IB2-IIIB cervical carcinoma: a retrospective review.

Ring KL, Young JL, Dunlap NE, Andersen WA, Schneider BF.

Am J Obstet Gynecol. 2009 Jul;201(1):109.e1-6. doi: 10.1016/j.ajog.2009.03.022. Epub 2009 Apr 26.

PMID:
19398095

Supplemental Content

Support Center